Fig. 1From: Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis\({SAWIS}_{i}\) for the network of 18 antidepressants for the acute treatment of major depressive disorder. The benefit spie chart included response and remission with weights 0.3 and 0.7, respectively, and the harm spie chart included dropout due to side effects and due to any cause with weights 0.7 and 0.3, respectivelyBack to article page